ESC 365 - Clinical significance of impaired cardiac conduction after alcohol septal ablation

ESC Premium Access

Clinical significance of impaired cardiac conduction after alcohol septal ablation

Session: Poster Session 4 - Treatment aspects of hypertrophic cardiomyopathy

Topic: Hypertrophic Cardiomyopathy

Speaker: Mr M. Jensen (Aarhus, DK)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Mr Morten Jensen

Aarhus University Hospital, Aarhus (Denmark)

0 follower

9 more presentations in this session

Predictors of ACEI/ ARB therapy in patients with hypertrophic cardiomyopathy: results of a national registry.

Speaker: Assistant Professor E. Martins (Porto, PT)

Efficacy and safety of dysopiramide in patients with obstructive hypertrophic cardiomyopathy

Speaker: Doctor C. Fumagalli (Florence, IT)

Result of surgical treatment of obstructive hypertrophic cardiomyopathy with coronary heart disease

Speaker: Doctor Y. Meng (Beijing, CN)

Comparative effectiveness of alcohol septal ablation versus septal myectomy on acute cardiovascular events in patients with hypertrophic cardiomyopathy

Speaker: Associate Professor H. Takayama (New York, US)

Predictors of long-term outcome after rescue surgical septal myectomy in hypertrophic obstructive cardiomyopathy patients with previous alcohol septal ablation

Speaker: Doctor C. Zhu (Beijing, CN)

Access the full session

Poster Session 4 - Treatment aspects of hypertrophic cardiomyopathy

Speakers: Mr M. Jensen, Assistant Professor E. Martins, Doctor C. Fumagalli, Doctor Y. Meng, Associate Professor H. Takayama...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources